worldwide interest in ALLERCA(TM)'s first lifestyle
pet drives price increase.
ANGELES, Jan. 19, 2005 -- ALLERCA(TM) Inc. today announced
a price increase on its first lifestyle pet, the ALLERCA(TM)
hypoallergenic cat. The price increases from $3,500
to $5,000 per kitten for U.S. clients and $8,500 for
increase is driven by the tremendous worldwide interest
in the ALLERCA(TM) cat. Even at a planned breeding
capacity of 200,000 kittens annually by 2010, ALLERCA(TM)
may be unable to meet worldwide demand.
received over $50 million in expressions of interest
and firm reservations in the first eight weeks following
the announcement to develop the hypoallergenic cat,
and the company projects an order book that will exceed
one billion dollars by the end of 2007.
officially launched the project to produce the world's
first hypoallergenic cat in October of 2004.
and development is already underway and ahead of schedule.
The birth of the first hypoallergenic kitten is expected
in 2006 and the very first customers will take delivery
response to the ALLERCA(TM) hypoallergenic cat has
been astonishing," states Simon Brodie, Chairman
and CEO of ALLERCA(TM) Inc. "Not only have we
seen a tremendous demand for our first lifestyle pet,
but I am astounded by the outpouring of support and
encouragement from animal lovers and allergy sufferers
continues: "Although some people have expressed
surprise at the cost or assume that the ALLERCA(TM)
cat is only for the very rich, our client base proves
is a large sector of the public who wants the companionship
of a hypoallergenic cat for themselves and their family.
These clients may consider the ALLERCA(TM) kitten
a luxury purchase, but agree the cats are worth the
price. We have also seen clients reserve two or more
Brodie expressed surprise at
how quickly ALLERCA(TM) has become recognizable on
a global basis. "People everywhere seem to know
ALLERCA(TM). We plan to establish ALLERCA(TM) as the
de facto lifestyle pet company, but the speed at which
the brand has become generally recognized did take
us by surprise. I recently overheard one person tell
another how they want an ALLERCA(TM): not a pet, not
a cat, but an ALLERCA(TM)."
The financial community has
also shown great interest in ALLERCA(TM). The company
has been featured in much of the financial press and
the online financial website The Motley Fool named
ALLERCA(TM) a "Future Rule Breaker."
ALLERCA(TM) Inc. is a biotechnology
company working with leading genetic technologies
focusing on animal genetics, research and development.
ALLERCA(TM) is currently developing the world's first
hypoallergenic cat, expected in 2006. ALLERCA(TM)
Inc. is headquartered in Los Angeles, California,
and maintains an international presence in Europe,
Japan, Australia and Latin America. Read more at http://www.allerca.com
11400 W. Olympic Blvd, Suite 200
Los Angeles, CA 90064